MedTrace Logo

Comparison of Glucovance to Insulin for Diabetes During Pregnancy

NCT00371306 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2007-04-20

No results posted yet for this study

Summary

Pregnant women with gestational or Type 2 diabetes who require medication are placed in one of two groups: Insulin injections or Glucovance (oral administration). Blood glucose is checked 5 times per day, and medication adjusted by perinatologist according to glucose levels. The hypothesis is that patients will have similar or improved blood glucose control on an oral agent as compared to control on insulin.

Conditions

Interventions

DRUG

Insulin versus glucovance (glyburide/metformin)

Sponsors & Collaborators

  • Regional Obstetrical Consultants

    lead OTHER

Principal Investigators

  • Joseph H Kipikasa, MD · Regional Obstetrical Consultants; UT Chattanooga OB-GYN Department

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-09-30
Completion
2008-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00371306 on ClinicalTrials.gov